Blood gene expression signatures predict invasive candidiasis

Science Translational Medicine

Volumn 2, Issue 21, 2010, Pages

  Zaas, Aimee K ^a,b   Aziz, Hamza ^b   Lucas, Joseph ^a   Perfect, John R ^b   Ginsburg, Geoffrey S ^a,b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CATHEPSIN B; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; PROTEIN BCL 2; RNA; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT2; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BLOODSTREAM INFECTION; CANDIDA ALBICANS; CELL ACTIVATION; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE DURATION; FALSE NEGATIVE RESULT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HOST RESISTANCE; IMMUNE STATUS; INVASIVE CANDIDIASIS; MALE; MOUSE; NONHUMAN; PATHOGEN LOAD; PREDICTION; PRIORITY JOURNAL; PROCESS MODEL; PROGNOSIS; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS; VALIDATION PROCESS; WEIGHT REDUCTION;

ALGORITHMS; ANIMALS; BACTEREMIA; CANDIDA ALBICANS; CANDIDIASIS; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; MALE; MICE; MICE, INBRED BALB C; SPECIES SPECIFICITY; TIME FACTORS;

EID: 77953006998     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3000715     Document Type: Article

References (55)

1. M. S. Rangel-Frausto, The epidemiology of bacterial sepsis. Infect. Dis. Clin. North Am. 13, 299-312 (1999).
2. M. B. Edmond, S. E. Wallace, D. K. McClish, M. A. Pfaller, R. N. Jones, R. P. Wenzel, Nosocomial bloodstream infections in United States hospitals: A three-year analysis. Clin. Infect. Dis. 29, 239-244 (1999).
3. M. Bassetti, E. Righi, M. Tumbarello, A. Di Biagio, R. Rosso, C. Viscoli, Candida infections in the intensive care unit: Epidemiology, risk factors and therapeutic strategies. Expert Rev. Anti Infect. Ther. 4, 875-885 (2006).
4. P. Sandven, L. Bevanger, A. Digranes, H. H. Haukland, T. Mannsåker, P. Gaustad; Norwegian Yeast Study Group, Candidemia in Norway (1991 to 2003): Results from a nationwide study. J. Clin. Microbiol. 44, 1977-1981 (2006).
5. J. R. Perfect, W. A. Schell, The new fungal opportunists are coming. Clin. Infect. Dis. 22, S112-S118 (1996).
6. T. E. Zaoutis, J. Argon, J. Chu, J. A. Berlin, T. J. Walsh, C. Feudtner, The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: A propensity analysis. Clin. Infect. Dis. 41, 1232-1239 (2005).
7. K. W. Garey, M. Rege, M. P. Pai, D. E. Mingo, K. J. Suda, R. S. Turpin, D. T. Bearden, Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multiinstitutional study. Clin. Infect. Dis. 43, 25-31 (2006).
8. M. Morrell, V. J. Fraser, M. H. Kollef, Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: A potential risk factor for hospital mortality. Antimicrob. Agents Chemother. 49, 3640-3645 (2005).
9. L. Ostrosky-Zeichner, C. Sable, J. Sobel, B. D. Alexander, G. Donowitz, V. Kan, C. A. Kauffman, D. Kett, R. A. Larsen, V. Morrison, M. Nucci, P. G. Pappas, M. E. Bradley, S. Major, L. Zimmer, D. Wallace, W. E. Dismukes, J. H. Rex, Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur. J. Clin. Microbiol. Infect. Dis. 26, 271-276 (2007).
10. J. Berenguer, M. Buck, F. Witebsky, F. Stock, P. A. Pizzo, T. J. Walsh, Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection. Diagn. Microbiol. Infect. Dis. 17, 103-109 (1993).
11. C. León, S. Ruiz-Santana, P. Saavedra, B. Almirante, J. Nolla-Salas, F. Alvarez-Lerma, J. Garnacho-Montero, M. A. León; EPCAN Study Group, A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit. Care Med. 34, 730-737 (2006).
12. N. I. Paphitou, L. Ostrosky-Zeichner, J. H. Rex, Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: Approach to developing practical criteria for systematic use in antifungal prophylaxis trials. Med. Mycol. 43, 235-243 (2005).
13. C. León, S. Ruiz-Santana, P. Saavedra, B. Galván, A. Blanco, C. Castro, C. Balasini, A. Utande-Vázquez, F. J. González de Molina, M. A. Blasco-Navalproto, M. J. López, P. E. Charles, E. Martín, M. A. Hernández-Viera; Cava Study Group, Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter study. Crit. Care Med. 37, 1624-1633 (2009).
14. Z. Odabasi, G. Mattiuzzi, E. Estey, H. Kantarjian, F. Saeki, R. J. Ridge, P. A. Ketchum, M. A. Finkelman, J. H. Rex, L. Ostrosky-Zeichner, β-D-Glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin. Infect. Dis. 39, 199-205 (2004). (Pubitemid 38971490)
15. S. Koo, J. M. Bryar, J. H. Page, L. R. Baden, F. M. Marty, Diagnostic performance of the (1→3)-β-D-glucan assay for invasive fungal disease. Clin. Infect. Dis. 49, 1650-1659 (2009).
16. M. G. Netea, G. D. Brown, B. J. Kullberg, N. A. Gow, An integrated model of the recognition of Candida albicans by the innate immune system. Nat. Rev. Microbiol. 6, 67-78 (2008).
17. J. C. Boldrick, A. A. Alizadeh, M. Diehn, S. Dudoit, C. L. Liu, C. E. Belcher, D. Botstein, L.M. Staudt, P. O. Brown, D. A. Relman, Stereotyped and specific gene expression programs in human innate immune responses to bacteria. Proc. Natl. Acad. Sci. U.S.A. 99, 972-977 (2002).
18. J. Kawada, H. Kimura, Y. Kamachi, K. Nishikawa, M. Taniguchi, K. Nagaoka, H. Kurahashi, S. Kojima, T. Morishima, Analysis of gene-expression profiles by oligonucleotide microarray in children with influenza. J. Gen. Virol. 87, 1677-1683 (2006).
19. R. G. Jenner, R. A. Young, Insights into host responses against pathogens from transcriptional profiling. Nat. Rev. Microbiol. 3, 281-294 (2005).
20. E. Huang, S. H. Cheng, H. Dressman, J. Pittman, M. H. Tsou, C. F. Horng, A. Bild, E. S. Iversen, M. Liao, C. M. Chen, M. West, J. R. Nevins, A. T. Huang, Gene expression predictors of breast cancer outcomes. Lancet 361, 1590-1596 (2003).
21. H. S. Kim, E. H. Choi, J. Khan, E. Roilides, A. Francesconi, M. Kasai, T. Sein, R. L. Schaufele, K. Sakurai, C. G. Son, B. T. Greer, S. Chanock, C. A. Lyman, T. J. Walsh, Expression of genes encoding innate host defense molecules in normal human monocytes in response to Candida albicans. Infect. Immun. 73, 3714-3724 (2005).
22. H. Aziz, A. K. Zaas, J. E. Lucas, J. R. Perfect, G. S. Ginsburg, Gene expression signatures predict invasive candidiasis, in 48th Annual Meeting of the Infectious Diseases Society of America (ASM Press, Washington, 2008).
23. O. Ramilo, W. Allman, W. Chung, A. Mejias, M. Ardura, C. Glaser, K. M. Wittkowski, B. Piqueras, J. Banchereau, A. K. Palucka, D. Chaussabel, Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 109, 2066-2077 (2007).
24. A. K. Zaas, M. Chen, J. Varkey, A. O. Hero III, J. Lucas, Y. Huang, R. Turner, A. Gilbert, R. Lambkin-Williams, N. C. Øien, B. Nicholson, S. Kingsmore, L. Carin, C. W. Woods, G. S. Ginsburg, Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell Host Microbe 6, 207-217 (2009).
25. D. Seo, T. Wang, H. Dressman, E. E. Herderick, E. S. Iversen, C. Dong, K. Vata, C. A. Milano, F. Rigat, J. Pittman, J. R. Nevins, M. West, P. J. Goldschmidt-Clermont, Gene expression phenotypes of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24, 1922-1927 (2004).
26. J. Brieland, D. Essig, C. Jackson, D. Frank, D. Loebenberg, F. Menzel, B. Arnold, B. DiDomenico, R. Hare, Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice. Infect. Immun. 69, 5046-5055 (2001).
27. H. K. Dressman, G. G. Muramoto, N. J. Chao, S. Meadows, D. Marshall, G. S. Ginsburg, J. R. Nevins, J. P. Chute, Gene expression signatures that predict radiation exposure in mice and humans. PLoS Med. 4, e106 (2007).
28. B. Spellberg, A. S. Ibrahim, J. E. Edwards Jr., S. G. Filler, Mice with disseminated candidiasis die of progressive sepsis. J. Infect. Dis. 192, 336-343 (2005).
29. G. Overland, J. F. Stuestøl, M. K. Dahle, A. E. Myhre, M. G. Netea, P. Verweij, A. Yndestad, P. Aukrust, B. J. Kullberg, A. Warris, J. E. Wang, A. O. Aasen, Cytokine responses to fungal pathogens in Kupffer cells are Toll-like receptor 4 independent and mediated by tyrosine kinases. Scand. J. Immunol. 62, 148-154 (2005).
30. M. G. Netea, N. A. Gow, C. A. Munro, S. Bates, C. Collins, G. Ferwerda, R. P. Hobson, G. Bertram, H. B. Hughes, T. Jansen, L. Jacobs, E. T. Buurman, K. Gijzen, D. L. Williams, R. Torensma, A.McKinnon, D. M. MaCcallum, F. C. Odds, J. W. Van der Meer, A. J. Brown, B. J. Kullberg, Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J. Clin. Invest. 116, 1642-1650 (2006).
31. H. S. Goodridge, R. M. Simmons, D. M. Underhill, Dectin-1 stimulation by Candida albicans yeast or zymosan triggers NFAT activation in macrophages and dendritic cells. J. Immunol. 178, 3107-3115 (2007).
32. F. L. van de Veerdonk, L. A. Joosten, I. Devesa, H. M. Mora-Montes, T. D. Kanneganti, C. A. Dinarello, J. W. van der Meer, N. A. Gow, B. J. Kullberg, M. G. Netea, Bypassing pathogeninduced inflammasome activation for the regulation of interleukin-1b production by the fungal pathogen Candida albicans. J. Infect. Dis. 199, 1087-1096 (2009).
33. A. G. Hise, J. Tomalka, S. Ganesan, K. Patel, B. A. Hall, G. D. Brown, K. A. Fitzgerald, An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 5, 487-497 (2009).
34. O. Gross, A. Gewies, K. Finger, M. Schäfer, T. Sparwasser, C. Peschel, I. Förster, J. Ruland, Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 442, 651-656 (2006).
35. S. E. Evans, B. L. Scott, C. G. Clement, D. T. Larson, D. Kontoyiannis, R. E. Lewis, P. R. Lasala, J. Pawlik, J. W. Peterson, A. K. Chopra, G. Klimpel, G. Bowden, M. Höök, Y. Xu, M. J. Tuvim, B. F. Dickey, Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi. Am. J. Respir. Cell Mol. Biol. 42, 40-50 (2010).
36. K. Luther, M. Rohde, K. Sturm, A. Kotz, J. Heesemann, F. Ebel, Characterisation of the phagocytic uptake of Aspergillus fumigatus conidia by macrophages. Microbes Infect. 10, 175-184 (2008).
37. W. J. Steinbach, R. A. Cramer Jr., B. Z. Perfect, C. Henn, K. Nielsen, J. Heitman, J. R. Perfect, Calcineurin inhibition or mutation enhances cell wall inhibitors against Aspergillus fumigatus. Antimicrob. Agents Chemother. 51, 2979-2981 (2007).
38. C. Fradin, P. De Groot, D. MaCcallum, M. Schaller, F. Klis, F. C. Odds, B. Hube, Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood. Mol. Microbiol. 56, 397-415 (2005).
39. C. Fradin, M. Kretschmar, T. Nichterlein, C. Gaillardin, C. d'Enfert, B. Hube, Stage-specific gene expression of Candida albicans in human blood. Mol. Microbiol. 47, 1523-1543 (2003). (Pubitemid 36363337)
40. M. C. Lorenz, J. A. Bender, G. R. Fink, Transcriptional response of Candida albicans upon internalization by macrophages. Eukaryot. Cell 3, 1076-1087 (2004).
41. I. Rubin-Bejerano, I. Fraser, P. Grisafi, G. R. Fink, Phagocytosis by neutrophils induces an amino acid deprivation response in Saccharomyces cerevisiae and Candida albicans. Proc. Natl. Acad. Sci. U.S.A. 100, 11007-11012 (2003).
42. C. Fradin, A. L. Mavor, G. Weindl, M. Schaller, K. Hanke, S. H. Kaufmann, H. Mollenkopf, B. Hube, The early transcriptional response of human granulocytes to infection with Candida albicans is not essential for killing but reflects cellular communications. Infect. Immun. 75, 1493-1501 (2007).
43. D. M. MaCcallum, L. Castillo, A. J. Brown, N. A. Gow, F. C. Odds, Early-expressed chemokines predict kidney immunopathology in experimental disseminated Candida albicans infections. PLoS One 4, e6420 (2009).
44. D. M. MaCcallum, Massive induction of innate immune response to Candida albicans in the kidney in a murine intravenous challenge model. FEMS Yeast Res. 9, 1111-1122 (2009).
45. F. F. Alam, A. S. Mustafa, Z. U. Khan, Comparative evaluation of (1, 3)-β-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia. BMC Infect. Dis. 7, 103 (2007).
46. F. Botterel, C. Farrugia, P. Ichai, J. M. Costa, F. Saliba, S. Bretagne, Real-time PCR on the first galactomannan-positive serum sample for diagnosing invasive aspergillosis in liver transplant recipients. Transpl. Infect. Dis. 10, 333-338 (2008).
47. M. Barenco, J. Stark, D. Brewer, D. Tomescu, R. Callard, M. Hubank, Correction of scaling mismatches in oligonucleotide microarray data. BMC Bioinformatics 7, 251 (2006).
48. D. M. Seo, P. J. Goldschmidt-Clermont, M. West, Of mice and men: Sparse statistical modeling in cardiovascular genomics. Ann. Appl. Stat. 1, 152-178 (2007).
49. J. E. Lucas, C. M. Carvalho, J.-Y. Chen, J.-T. Chi, M. West, Sparse statistical modeling in gene expression genomics, in Bayesian Inference for Gene Expression and Proteomics (Cambridge Univ. Press, New York, 2006), pp. 155-176.
50. A. E. Raftery, D. Madigan, J. A. Hoeting, Bayesian model averaging for linear regression models. J. Am. Stat. Assoc. 92, 179-191 (1997).
51. C. Hans, A. Dobra, M. West, Shotgun stochastic search for "Large p" regression. J. Am. Stat. Assoc. 102, 507-516 (2007).
52. J. E. Lucas, C. Carvalho, D. Merl, M. West, In-vitro to in-vivo factor profiling in expression genomics, in Bayesian Modelling in Bioinformatics, D. Dey, S. Ghosh, B.Mallick, Eds. (Taylor-Francis, in press).
53. J. E. Lucas, C. Carvalho, M. West, A Bayesian analysis strategy for cross-study translation of gene expression biomarkers. Stat. Appl. Genet. Mol. Biol. 8, Article 11 (2009).
54. J. E. Lucas, C. M. Carvalho, J. L. Chen, J. T. Chi, M. West, Cross-study projections of genomic biomarkers: An evaluation in cancer genomics. PLoS One 4, e4523 (2009).
55. J. T. Chang, J. R. Nevins, GATHER: A systems approach to interpreting genomic signatures. Bioinformatics 22, 2926-2933 (2006).